...
首页> 外文期刊>Journal of Pharmacy and Bioallied Sciences >Myocardial infarction and stem cells
【24h】

Myocardial infarction and stem cells

机译:心肌梗塞和干细胞

获取原文
           

摘要

Permanent loss of cardiomyocytes and scar tissue formation after myocardial infarction (MI) results in an irreversible damage to the cardiac function. Cardiac repair (replacement, restoration, and regeneration) is, therefore, essential to restore function of the heart following MI. Existing therapies lower early mortality rates, prevent additional damage to the heart muscle, and reduce the risk of further heart attacks. However, there is need for treatment to improve the infarcted area by replacing the damaged cells after MI. Thus, the cardiac tissue regeneration with the application of stem cells may be an effective therapeutic option. Recently, interest is more inclined toward myocardial regeneration with the application of stem cells. However, the potential benefits and the ability to improve cardiac function with the stem cell-based therapy need to be further addressed. In this review, we focus on the clinical applications of stem cells in the cardiac repair.Keywords: Cardiomyocytes, myocardial infarction, stem cells, stem cell transplantation
机译:心肌梗塞(MI)后心肌细胞的永久丢失和瘢痕组织形成导致心脏功能不可逆转的损害。因此,心脏修复(置换,恢复和再生)对于MI后恢复心脏功能至关重要。现有疗法降低了早期死亡率,防止了对心肌的进一步损害,并降低了进一步心脏病发作的风险。然而,需要通过在MI后更换受损细胞来改善梗塞区域的治疗。因此,应用干细胞进行心脏组织再生可能是一种有效的治疗选择。近来,随着干细胞的应用,人们对心肌再生的兴趣更加浓厚。然而,基于干细胞的疗法的潜在益处和改善心脏功能的能力需要进一步解决。本文综述了干细胞在心脏修复中的临床应用。关键词:心肌细胞,心肌梗死,干细胞,干细胞移植

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号